Does the transcription factor SALL4 regulate stemness of EpCAM-positive hepatocellular carcinoma?
SALL4 is a valuable biomarker and therapeutic target for the diagnosis and treatment of hepatocellular carcinoma with stem cell features.
Δ L-R in measurements provide limited explanations for V1 side preferences in elite XC skiers. In fact, no systematic relations exist between V1 side preferences and anthropometric, biomechanical, or questionnaire data.